Heidi Simmons

Heidi Simmons is the Director of Global Medical Reviewer at Karyopharm Therapeutics Inc., a position held since October 2025. Prior to this role, Heidi served as Director and Associate Director of Medical Affairs at Adaptive Biotechnologies Corp. from October 2019 to August 2025. Earlier experience includes working as a Senior Medical Science Liaison in Hematology at Celgene and a contractor focusing on Medical and Scientific Communications and Strategy at Vaniam Group. Furthermore, Heidi held the role of Research Scientific Director in Hematology at Merck from May 2016 to February 2017. Heidi Simmons earned a PhD in Cancer Genetics from the University of Minnesota and a B.S. in Biochemistry from Saint Mary's College.